Archives: Speakers

Yan Wang

Yan Wang, PhD in Biophysical Chemistry, has been working at MD Anderson since 2010. Started in Molecular Epidemiology research, Yan has joined the clinical research field in the Department of Investigational Cancer Therapeutics (Phase I Program) in 2016 and later moved on to the Department of Leukemia, providing patient care through clinical trials.

Vanessa Tassell

Ms. Tassell joined Mirati in October 2013 and was named Vice President of Clinical Science in October 2017. She has more than 20 years of experience in clinical drug development. Prior to joining Mirati, she was Senior Director of Clinical Development at Aragon Pharmaceuticals located in San Diego. At Aragon, she managed the apalutamide (ERLEADA™) program while it was in development and prior to the Aragon acquisition by Johnson & Johnson in 2013. Ms. Tassell’s experience includes positions of increasing responsibility at Pfizer from 2000-2013, which involved supporting clinical development activities for oncology programs including NDA submissions for sunitinib (SUTENT®) and crizotinib (XALKORI®). Ms. Tassell started her career with Parexel International in Boston, Massachusetts.  Ms. Tassell has a B.S. degree in Psychology from Northeastern University, Massachusetts.

 

Darrell Panich

Darrell J. Panich, M.Sc. PMP, CPM: An experienced clinical trial management specialist with over two decades experience in the industry, Mr. Panich has managed multinational clinical research studies in 21 different countries for over 20 different pharmaceutical and biotechnology companies. As President of Ceros Management and Advisory, he provides clinical operations and project management solutions to CROs, biotech, pharmaceutical companies. He has a passion for learning and has obtained a Master of Science in Psychiatry, two bachelors degrees, two project management certifications and an Honours Automotive Mechanic Certificate.

Andy Hartman

Andy Hartman is the Director of Corporate Quality and Compliance at Horizon Therapeutics and his group is specifically focused on oversight of Horizon’s clinical development and LCM development products/projects. Andy has held roles of increasing responsibility in sponsor organizations in Quality Control, Regulatory CMC, and Quality Assurance. His experiences have included work on pre-clinical candidates, product launches, products marketed for greater than 30 years, and everything in between.